Table 2 The estimated benefit of ventilation therapy among patients of different age groups with various underlying conditions.

From: Exploring the clinical benefit of ventilation therapy across various patient groups with COVID-19 using real-world data

id	COPD	Malignancy	CVD	DM	Age	Benefit^a	P-value	Observation (Total^b)	Observation (Ventilation^c)	Observation (Recovery^d)
1	No	No	No	No	18–39	1.983	< 0.001	103,991	8574	100,269
2	No	No	No	No	40–64	1.728	< 0.001	171,041	14,566	155,469
3	No	No	No	No	65 +	1.369	< 0.001	139,453	14,014	108,579
4	No	No	No	Yes	18–39	1.267	N/S	2827	288	2654
5	No	No	No	Yes	40–64	1.455	< 0.001	22,096	2214	19,465
6	No	No	No	Yes	65 +	1.72	< 0.001	23,258	2705	17,752
7	No	No	Yes	No	18–39	1.836	0.008	2895	336	2667
8	No	No	Yes	No	40–64	1.31	< 0.001	22,712	2539	20,251
9	No	No	Yes	No	65 +	1.266	< 0.001	43,934	5722	34,249
10	No	No	Yes	Yes	18–39	− 2.412	N/S	401	46	361
11	No	No	Yes	Yes	40–64	1.877	< 0.001	10,660	1276	9088
12	No	No	Yes	Yes	65 +	1.427	< 0.001	19,903	2598	15,205
13	No	Yes	No	No	18–39	3.639	< 0.001	1136	136	858
14	No	Yes	No	No	40–64	1.255	0.004	3788	528	2816
15	No	Yes	No	No	65 +	0.691	N/S	3085	501	2098
16	No	Yes	No	Yes	18–39	N/A	N/A	16	2	15
17	No	Yes	No	Yes	40–64	− 0.324	N/S	313	44	242
18	No	Yes	No	Yes	65 +	2.592	N/S	388	72	258
19	No	Yes	Yes	No	18–39	N/A	N/A	21	6	16
20	No	Yes	Yes	No	40–64	− 0.808	N/S	234	44	181
21	No	Yes	Yes	No	65 +	1.867	N/S	617	111	440
22	No	Yes	Yes	Yes	18–39	N/A	N/A	7	1	6
23	No	Yes	Yes	Yes	40–64	4.885	N/S	132	16	99
24	No	Yes	Yes	Yes	65 +	3.79	0.049	279	45	206
25	Yes	No	No	No	18–39	0.499	N/S	1685	238	1582
26	Yes	No	No	No	40–64	0.873	0.041	5958	721	5204
27	Yes	No	No	No	65 +	0.466	N/S	7095	1015	5391
28	Yes	No	No	Yes	18–39	241.684	N/S	44	8	40
29	Yes	No	No	Yes	40–64	3.137	0.005	834	123	696
30	Yes	No	No	Yes	65 +	0.605	N/S	1295	172	977
31	Yes	No	Yes	No	18–39	445.595	N/S	131	14	118
32	Yes	No	Yes	No	40–64	0.651	N/S	1599	221	1348
33	Yes	No	Yes	No	65 +	0.76	0.032	4488	730	3329
34	Yes	No	Yes	Yes	18–39	N/A	N/A	21	3	18
35	Yes	No	Yes	Yes	40–64	0.934	N/S	698	105	572
36	Yes	No	Yes	Yes	65 +	2.473	< 0.001	1711	277	1274
37	Yes	Yes	No	No	18–39	− 383.91	N/S	34	6	25
38	Yes	Yes	No	No	40–64	6.504	0.017	183	31	120
39	Yes	Yes	No	No	65 +	− 0.061	0.982	182	29	120
40	Yes	Yes	No	Yes	40–64	N/A	N/A	14	1	11
41	Yes	Yes	No	Yes	65 +	− 338.243	1.00	31	4	22
42	Yes	Yes	Yes	No	18–39	N/A	N/A	1	0	1
43	Yes	Yes	Yes	No	40–64	− 6.389	1.00	24	5	15
44	Yes	Yes	Yes	No	65 +	− 3.169	0.494	80	16	49
45	Yes	Yes	Yes	Yes	18–39	N/A	N/A	1	1	1
46	Yes	Yes	Yes	Yes	40–64	N/A	N/A	12	2	9
47	Yes	Yes	Yes	Yes	65 +	1466.119	0.999	32	7	16

^aThe interaction coefficient of the second model.
^bThe total number of patients with COVID-19 who were admitted to the hospital in each group.
^cThe total number of patients with COVID-19 who received ventilation therapy in each group.
^dThe total number of patients with COVID-19 who recovered after hospital admission in each group.

Back to article page

Table 2 The estimated benefit of ventilation therapy among patients of different age groups with various underlying conditions.

Search

Quick links